EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 22 filers reported holding EVOKE PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 87,925 | $48,000 | 0.01% |
Wambolt & Associates, LLC | 32,000 | $18,000 | 0.01% |
Virtu Financial LLC | 55,336 | $31,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 183 | $0 | 0.00% |
NORTHERN TRUST CORP | 42,121 | $23,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 3,828 | $2,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 210,102 | $117,000 | 0.00% |
STATE STREET CORP | 72,800 | $41,000 | 0.00% |
MORGAN STANLEY | 9,606 | $5,000 | 0.00% |